Urakami, Tatsuhiko
Hotsubo, Tomoyuki
Ogawa, Yohei
Kikuchi, Toru
Usuda, Rika
Matsui, Katsuyuki
Hirose, Masakazu
Hirai, Hiroki
Abiru, Norio
Fujiwara, Ikuma
Mizuno, Haruo
Miyako, Kenichi
Takahashi, Kazuma
Shimada, Akira
,
Article History
Received: 5 June 2024
First Online: 15 August 2024
Declarations
:
: Tatsuhiko Urakami: lecture fees (Novo Nordisk Pharma Ltd., Terumo Corporation, Abbott Japan LLC, and JCR Pharmaceutical Co., Ltd.); Toru Kikuchi: lecture fees (Eli Lilly Japan K.K. and Taisho Pharmaceutical Co., Ltd.) and manuscript fees (MTI Ltd.); Norio Abiru: lecture fees (Novo Nordisk Pharma Ltd. and Eli Lilly Japan K.K.); Ikuma Fujiwara: research funds, grants, etc. (Pfizer Japan Inc.)